Last updated on July 2019

Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia


Brief description of study

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.

Clinical Study Identifier: NCT03896945

Find a site near you

Start Over

Clinical Research Site

Jamaica, NY United States
2.87miles
  Connect »

Clinical Research Site

New York, NY United States
7.01miles
  Connect »